Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 80,000 shares at $8.37 ($670K) on 2019-12-23, disclosed to the SEC on 2019-12-26.
Open-market sale of $670k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.37 | 40,000 | $335K | 50.0% |
| 2 | $8.37 | 40,000 | $335K | 50.0% |
| Total | $8.37 avg | 80,000 | $670K | 100% |
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |